These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 24905095)
1. Synaptonemal complex protein 3 is a prognostic marker in cervical cancer. Cho H; Noh KH; Chung JY; Takikita M; Chung EJ; Kim BW; Hewitt SM; Kim TW; Kim JH PLoS One; 2014; 9(6):e98712. PubMed ID: 24905095 [TBL] [Abstract][Full Text] [Related]
2. Interaction between SCP3 and JAB1 Confers Cancer Therapeutic Resistance and Stem-like Properties through EGF Expression. Oh SJ; Noh KH; Song KH; Kim TW Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445562 [TBL] [Abstract][Full Text] [Related]
3. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486 [TBL] [Abstract][Full Text] [Related]
4. High-mobility group box 2 promoted proliferation of cervical cancer cells by activating AKT signaling pathway. Zhang P; Lu Y; Gao S J Cell Biochem; 2019 Oct; 120(10):17345-17353. PubMed ID: 31209930 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis. Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603 [TBL] [Abstract][Full Text] [Related]
6. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway. Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer. Cho H; Chung JY; Song KH; Noh KH; Kim BW; Chung EJ; Ylaya K; Kim JH; Kim TW; Hewitt SM; Kim JH BMC Cancer; 2014 Jul; 14():545. PubMed ID: 25070070 [TBL] [Abstract][Full Text] [Related]
8. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis. Jin X; Jiao X; Jiao J; Zhang T; Cui B Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735 [TBL] [Abstract][Full Text] [Related]
10. p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis. Jiang C; Xu R; Li XX; Wang YY; Liang WQ; Zeng JD; Zhang SS; Xu XY; Yang Y; Zhang MY; Wang HY; Zheng XFS Cell Cycle; 2017 Sep; 16(18):1673-1682. PubMed ID: 28841361 [TBL] [Abstract][Full Text] [Related]
11. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Tanaka T; Terai Y; Kogata Y; Ashihara K; Maeda K; Fujiwara S; Yoo S; Tanaka Y; Tsunetoh S; Sasaki H; Kanemura M; Tanabe A; Ohmichi M Oncol Rep; 2015 Nov; 34(5):2282-8. PubMed ID: 26351781 [TBL] [Abstract][Full Text] [Related]
12. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer. Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741 [TBL] [Abstract][Full Text] [Related]
13. PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway. Shu XR; Wu J; Sun H; Chi LQ; Wang JH Diagn Pathol; 2015 Sep; 10():177. PubMed ID: 26411419 [TBL] [Abstract][Full Text] [Related]
14. Wnt-11 overexpression promoting the invasion of cervical cancer cells. Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261 [TBL] [Abstract][Full Text] [Related]
15. Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. Cho H; Kim JS; Chung H; Perry C; Lee H; Kim JH Hum Pathol; 2013 Jul; 44(7):1365-74. PubMed ID: 23427874 [TBL] [Abstract][Full Text] [Related]
16. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1/2 through the receptor ErbB2. Li S; Ma YM; Zheng PS; Zhang P J Exp Clin Cancer Res; 2018 Apr; 37(1):80. PubMed ID: 29636108 [TBL] [Abstract][Full Text] [Related]
17. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer. Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172 [TBL] [Abstract][Full Text] [Related]
18. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway. Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981 [TBL] [Abstract][Full Text] [Related]
19. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway. Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035 [TBL] [Abstract][Full Text] [Related]
20. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer. Zhang X; Liu S; Zhu Y Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]